Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Lenograstim × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 2 Hodgkin Disease 1

Interventions

Cyclophosphamide 77 fludarabine phosphate 76 Mycophenolic Acid 56 Peripheral Blood Stem Cell Transplantation 54 Whole-Body Irradiation 53 Tacrolimus 47 Cyclosporine 40 Busulfan 37 Antilymphocyte Serum 34 fludarabine 32 Filgrastim 31 Melphalan 29 Radiotherapy 25 Methotrexate 21 Granulocyte Colony-Stimulating Factor 18 Sirolimus 17 Etoposide 15 Cord Blood Stem Cell Transplantation 15 Methylprednisolone 14 Rituximab 13 thymoglobulin 11 Stem Cell Transplantation 11 Flow Cytometry 10 Cyclosporins 10 Alemtuzumab 10 Therapeutics 9 Cytarabine 9 plerixafor 8 Psychiatric Rehabilitation 8 Thiotepa 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085058 2010-03-11

CU01

WiSP Wissenschaftlicher Service Pharma GmbH

Phase 2/3 Completed

LymphoidPlasma cell

Hodgkin Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡